Publications by authors named "T Vergou"

Claim this Profile
R
Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas.
Natalia Rompoti, Theognosia Vergou, Irene Stefanaki, Charitomeni Vavouli, Ioannis-Alexios Koumprentziotis

Int J Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermo-cosmetic spray containing Rhealba oat plantlets and Uncaria tomentosa extract in patients with mild-to-moderate cutaneous pain.
A Stockman, A Belpaire, I M Hadshiew, M Žemličkova, T Vergou

J Eur Acad Dermatol Venereol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy.
Anastasios Karamanakos, Theognosia Vergou, Stylianos Panopoulos, Maria G Tektonidou, Alexander J Stratigos

Eur J Dermatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.
A Petridis, P Panagakis, E Moustou, T Vergou, P Kallidis

J Eur Acad Dermatol Venereol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year experience with Ustekinumab for psoriasis: real-life data of a single centre.
T Vergou, A E Moustou, C Antoniou

J Eur Acad Dermatol Venereol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis